151 related articles for article (PubMed ID: 34436036)
21. Patterns of care and survival among small cell lung cancer patients: Experience from a tertiary center in India.
Julka PK; Sharma DN; Madan R; Mallick S; Benson R; Kunhi P H; Gupta S; Rath GK
J Egypt Natl Canc Inst; 2017 Mar; 29(1):47-51. PubMed ID: 27856126
[TBL] [Abstract][Full Text] [Related]
22. Comparison of First-Line Treatments for Patients With Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-analysis.
Zhou T; Zhang Z; Luo F; Zhao Y; Hou X; Liu T; Wang K; Zhao H; Huang Y; Zhang L
JAMA Netw Open; 2020 Oct; 3(10):e2015748. PubMed ID: 33074323
[TBL] [Abstract][Full Text] [Related]
23. [Second-line chemotherapy and its survival analysis of 181 patients with extensive-stage small cell lung cancer in a single institute].
Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
Zhongguo Fei Ai Za Zhi; 2013 Nov; 16(11):572-8. PubMed ID: 24229622
[TBL] [Abstract][Full Text] [Related]
24. Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy.
Sun A; Durocher-Allen LD; Ellis PM; Ung YC; Goffin JR; Ramchandar K; Darling G
Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):658-666. PubMed ID: 30007803
[TBL] [Abstract][Full Text] [Related]
25. Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer.
Cramer-van der Welle CM; Schramel FMNH; van Leeuwen AS; Groen HJM; van de Garde EMW;
Eur J Cancer Care (Engl); 2020 Sep; 29(5):e13250. PubMed ID: 32406593
[TBL] [Abstract][Full Text] [Related]
26. Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma.
O'Sullivan DE; Boyne DJ; Syed IA; Shephard C; Clouthier DL; Yoshida EM; Spratlin JL; Batra A; Rigo R; Hannouf M; Yang Hu X; N Jarada T; Brenner DR; Cheung WY
Can Liver J; 2022 Nov; 5(4):476-492. PubMed ID: 38144405
[No Abstract] [Full Text] [Related]
27. Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study.
Borghaei H; Pundole X; Sangaré L; Anderson E; Bebb DG; Jiang T; Pastel M; Carrigan G; Balasubramanian A; Martinez P; Ramalingam SS
Lung Cancer; 2024 May; 193():107819. PubMed ID: 38865854
[TBL] [Abstract][Full Text] [Related]
28. Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017.
Lattuca-Truc M; Timsit JF; Levra MG; Ruckly S; Villa J; Dumas I; Pinsolle J; Ferrer L; Guillem P; Moro-Sibilot D; Toffart AC;
Lung Cancer; 2019 May; 131():122-127. PubMed ID: 31027688
[TBL] [Abstract][Full Text] [Related]
29. Current patterns of care for patients with extensive stage small cell lung cancer: Survey of US radiation oncologists on their recommendations regarding thoracic consolidation radiotherapy.
Mitin T; Jain A; Degnin C; Chen Y; Henderson M; Thomas CR
Lung Cancer; 2016 Oct; 100():85-89. PubMed ID: 27597285
[TBL] [Abstract][Full Text] [Related]
30. Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Goldman JW; Dvorkin M; Chen Y; Reinmuth N; Hotta K; Trukhin D; Statsenko G; Hochmair MJ; Özgüroğlu M; Ji JH; Garassino MC; Voitko O; Poltoratskiy A; Ponce S; Verderame F; Havel L; Bondarenko I; Każarnowicz A; Losonczy G; Conev NV; Armstrong J; Byrne N; Thiyagarajah P; Jiang H; Paz-Ares L;
Lancet Oncol; 2021 Jan; 22(1):51-65. PubMed ID: 33285097
[TBL] [Abstract][Full Text] [Related]
31. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects.
Demedts IK; Vermaelen KY; van Meerbeeck JP
Eur Respir J; 2010 Jan; 35(1):202-15. PubMed ID: 20044461
[TBL] [Abstract][Full Text] [Related]
32. Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line - Results from the prospective German TLK cohort study.
Steffens CC; Elender C; Hutzschenreuter U; Dille S; Binninger A; Spring L; Jänicke M; Marschner N;
Lung Cancer; 2019 Apr; 130():216-225. PubMed ID: 30885347
[TBL] [Abstract][Full Text] [Related]
33. Prophylactic cranial irradiation in small cell lung cancer: A single institution experience.
Nicholls L; Keir GJ; Murphy MA; Mai T; Lehman M
Asia Pac J Clin Oncol; 2016 Dec; 12(4):415-420. PubMed ID: 27453519
[TBL] [Abstract][Full Text] [Related]
34. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Paz-Ares L; Dvorkin M; Chen Y; Reinmuth N; Hotta K; Trukhin D; Statsenko G; Hochmair MJ; Özgüroğlu M; Ji JH; Voitko O; Poltoratskiy A; Ponce S; Verderame F; Havel L; Bondarenko I; Kazarnowicz A; Losonczy G; Conev NV; Armstrong J; Byrne N; Shire N; Jiang H; Goldman JW;
Lancet; 2019 Nov; 394(10212):1929-1939. PubMed ID: 31590988
[TBL] [Abstract][Full Text] [Related]
35. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
[TBL] [Abstract][Full Text] [Related]
36. Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.
Pezzi TA; Schwartz DL; Mohamed ASR; Welsh JW; Komaki RU; Hahn SM; Sepesi B; Pezzi CM; Fuller CD; Chun SG
JAMA Oncol; 2018 Aug; 4(8):e174504. PubMed ID: 29302695
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer.
Igawa S; Otani S; Ryuge S; Fukui T; Nakahara Y; Hiyoshi Y; Ishihara M; Kusuhara S; Harada S; Mitsufuji H; Kubota M; Sasaki J; Masuda N
Invest New Drugs; 2017 Oct; 35(5):642-648. PubMed ID: 28631097
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute.
Sonehara K; Tateishi K; Fukushima T; Komatsu M; Yamamoto H; Koizumi T; Hanaoka M
Thorac Cancer; 2019 Sep; 10(9):1805-1811. PubMed ID: 31350820
[TBL] [Abstract][Full Text] [Related]
39. Use of Immunotherapy in Extensive-Stage Small Cell Lung Cancer.
Konala VM; Madhira BR; Ashraf S; Graziano S
Oncology; 2020; 98(11):749-754. PubMed ID: 32663833
[TBL] [Abstract][Full Text] [Related]
40. A Prospective Study of Apatinib in Patients with Extensive-Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy.
Liu Y; Hu X; Jiang J; Yang L; Zhou S; Liu P; Li J; Wang Y; Hao X; Shi Y
Oncologist; 2020 May; 25(5):e833-e842. PubMed ID: 32250517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
